About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 407031, 15 pages
http://dx.doi.org/10.1155/2011/407031
Review Article

Dysfunction of Lacrimal and Salivary Glands in Sjögren's Syndrome: Nonimmunologic Injury in Preinflammatory Phase and Mouse Model

Laboratory of Veterinary Pathology, Faculty of Agriculture, Yamaguchi University, 1677-1, Yoshida, Yamaguchi 753-8515, Japan

Received 13 October 2010; Revised 8 February 2011; Accepted 8 March 2011

Academic Editor: Oreste Gualillo

Copyright © 2011 Toshiharu Hayashi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Porola, M. Laine, L. Virkki, P. Poduval, and Y. T. Konttinen, “The influence of sex steroids on Sjögren's syndrome,” Annals of the New York Academy of Sciences, vol. 1108, pp. 426–432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. K. J. Bolch, W. W. Bluchanan, M. J. Wohl, and J. J. Bunim, “Sjögren's syndrome: clinical, pathological, and serological studies of sixty-two cases,” Medicine, vol. 44, pp. 187–231, 1965.
  3. T. E. W. Feltkamp, “Sjogren's syndrome in relation to other autoimmune diseases,” Netherlands Journal of Medicine, vol. 40, no. 3, pp. 105–107, 1992. View at Scopus
  4. L. G. Anderson and N. Talal, “The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome,” Clinical and Experimental Immunology, vol. 10, no. 2, pp. 199–221, 1972. View at Scopus
  5. C. P. Mavragani and H. M. Moutsopoulos, “The geoepidemiology of Sjögren's syndrome,” Autoimmunity Reviews, vol. 9, no. 5, pp. A305–A310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. D. I. Mitsias, E. K. Kapsogeorgou, and H. M. Moutsopoulos, “Sjögren's syndrome: why autoimmune epithelitis?” Oral Diseases, vol. 12, no. 6, pp. 523–532, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Nishimori, Y. Yamamoto, K. Okazaki et al., “Identification of autoantibodies to a pancreatic antigen in patients with idiopathic chronic pancreatitis and Sjögren's syndrome,” Pancreas, vol. 9, no. 3, pp. 374–381, 1994. View at Scopus
  8. R. H. Scofield, “Genetics of systemic lupus erythematosus and Sjögren's syndrome,” Current Opinion in Rheumatology, vol. 21, no. 5, pp. 448–453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. P. Mavragani and H. M. Moutsopoulos, “The geoepidemiology of Sjögren's syndrome,” Autoimmunity Reviews, vol. 9, no. 5, pp. A305–A310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Miceli-Richard, N. Gestermann, M. Ittah et al., “The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome,” Arthritis and Rheumatism, vol. 60, no. 7, pp. 1991–1997, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Miceli-Richard, E. Comets, P. Loiseau, X. Puechal, E. Hachulla, and X. Mariette, “Association of an IRF5 gene functional polymorphism with Sjögren's syndrome,” Arthritis and Rheumatism, vol. 56, no. 12, pp. 3989–3994, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Mamtani, J. M. Anaya, W. He, and S. K. Ahuja, “Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases,” Genes and Immunity, vol. 11, no. 2, pp. 155–160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Laine, P. Porola, L. Udby et al., “Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome,” Arthritis and Rheumatism, vol. 56, no. 8, pp. 2575–2584, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Porola, M. Laine, L. Virkki, P. Poduval, and Y. T. Konttinen, “The influence of sex steroids on Sjögren's syndrome,” Annals of the New York Academy of Sciences, vol. 1108, pp. 426–432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Porola, L. Virkki, B. D. Przybyla et al., “Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjögren's syndrome,” Journal of Rheumatology, vol. 35, no. 11, pp. 2229–2235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Sullivan, L. Block, and J. D. O. Pena, “Influence of androgens and pituitary hormones on the structural profile and secretory activity of the lacrimal gland,” Acta Ophthalmologica Scandinavica, vol. 74, no. 5, pp. 421–435, 1996. View at Scopus
  17. A. G. Tzioufas, J. Tsonis, and H. M. Moutsopoulos, “Neuroendocrine dysfunction in Sjögren's syndrome,” NeuroImmunoModulation, vol. 15, no. 1, pp. 37–45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. T. Konttinen, P. Porola, L. Konttinen, M. Laine, and P. Poduval, “Immunohistopathology of Sjögren's syndrome,” Autoimmunity Reviews, vol. 6, no. 1, pp. 16–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. N. P. Nikolov and G. G. Illei, “Pathogenesis of Sjögren's syndrome,” Current Opinion in Rheumatology, vol. 21, no. 5, pp. 465–470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Balada, J. Ordi-Ros, and M. Vilardell-Tarrés, “Molecular mechanisms mediated by Human Endogenous Retroviruses (HERVs) in autoimmunity,” Reviews in Medical Virology, vol. 19, no. 5, pp. 273–286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. E. Willoughby, K. Baker, S. B. Kaye et al., “Epstein-Barr virus (types 1 and 2) in the tear film in Sjögren's syndrome and HIV infection,” Journal of Medical Virology, vol. 68, no. 3, pp. 378–383, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. É. Toussirot and J. Roudier, “Epstein-Barr virus in autoimmune diseases,” Best Practice and Research, vol. 22, no. 5, pp. 883–896, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. P. J. W. Venables and S. P. Rigby, “Viruses in the etiopathogenesis of Sjögren's syndrome,” Journal of Rheumatology, vol. 24, no. 50, pp. 3–5, 1997. View at Scopus
  24. D. Moyes, A. Martin, S. Sawcer, N. Temperton, D. Griffiths, and P. Venables, “The distribution of the endogenous retroviruses HERV-K113 and-K115 in health and disease: HERV-K113 as a novel risk factor for Sjögren's syndrome,” Genomics, vol. 86, pp. 337–341, 2005.
  25. L.-J. Couderc, M.-F. D'Agay, F. Danon, M. Harzic, C. Brocheriou, and J. P. Clauvel, “Sicca complex and infection with human immunodeficiency virus,” Archives of Internal Medicine, vol. 147, pp. 898–901, 1987.
  26. R. Navone, C. Lunardi, R. Gerli et al., “Identification of tear lipocalin as a novel autoantigen target in Sjögren's syndrome,” Journal of Autoimmunity, vol. 25, no. 3, pp. 229–234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Francis and A. Perl, “Infection in systemic lupus erythematosus: friend or foe?” International Journal of Clinical Rheumatology, vol. 5, no. 1, pp. 59–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Amital, M. Govoni, R. Maya et al., “Role of infectious agents in systemic rheumatic diseases,” Clinical and Experimental Rheumatology, vol. 26, no. 1, pp. S27–S32, 2008. View at Scopus
  29. T. Kamradt, R. Göggel, and K. J. Erb, “Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection,” Trends in Immunology, vol. 26, no. 5, pp. 260–267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Vitali, S. Bombardieri, R. Jonsson et al., “Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group,” Annals of the Rheumatic Diseases, vol. 61, no. 6, pp. 554–558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. M. S. Soyfoo, S. Steinfeld, and C. Delporte, “Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome,” Oral Diseases, vol. 13, no. 4, pp. 366–375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Cha, A. B. Peck, and M. G. Humphreys-Beher, “Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update,” Critical Reviews in Oral Biology and Medicine, vol. 13, no. 1, pp. 5–16, 2002. View at Scopus
  33. C. P. Robinson, J. Cornelius, D. E. Bounous, H. Yamamoto, M. G. Humphreys-Beher, and A. B. Peck, “Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice,” Autoimmunity, vol. 27, no. 1, pp. 29–44, 1998. View at Scopus
  34. M. G. Humphreys-Beher, J. Brayer, S. Yamachika, A. B. Peck, and R. Jonsson, “An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression,” Scandinavian Journal of Immunology, vol. 49, no. 1, pp. 7–10, 1999. View at Scopus
  35. N. Talal, R. A. Sylvester, T. E. Daniels, J. S. Greenspan, and R. C. Williams Jr., “T and B lymphocytes in peripheral blood and tissue lesions in Sjögren's syndrome,” Journal of Clinical Investigation, vol. 53, no. 1, pp. 180–189, 1974. View at Scopus
  36. Y. Ohyama, S. Nakamura, G. Matsuzaki et al., “Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome,” Arthritis and Rheumatism, vol. 39, no. 8, pp. 1376–1384, 1996. View at Scopus
  37. R. I. Fox, H. I. Kang, D. Ando, J. Abrams, and E. Pisa, “Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome,” Journal of Immunology, vol. 152, no. 11, pp. 5532–5539, 1994. View at Scopus
  38. D. I. Mitsias, A. G. Tzioufas, C. Veiopoulou et al., “The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren's syndrome,” Clinical and Experimental Immunology, vol. 128, no. 3, pp. 562–568, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. G. E. Katsifis, S. Rekka, N. M. Moutsopoulos, S. Pillemer, and S. M. Wahl, “Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis,” American Journal of Pathology, vol. 175, no. 3, pp. 1167–1177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Espinosa, V. Dardalhon, S. Brauner et al., “Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway,” Journal of Experimental Medicine, vol. 206, no. 8, pp. 1661–1671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Sakai, Y. Sugawara, T. Kuroishi, T. Sasano, and S. Sugawara, “Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18,” Journal of Immunology, vol. 181, no. 4, pp. 2898–2906, 2008. View at Scopus
  42. C. Q. Nguyen, M. H. Hu, Y. Li, C. Stewart, and A. B. Peck, “Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice,” Arthritis and Rheumatism, vol. 58, no. 3, pp. 734–743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Espinosa, V. Dardalhon, S. Brauner et al., “Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway,” Journal of Experimental Medicine, vol. 206, no. 8, pp. 1661–1671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. R. I. Fox and H. I. Kang, “Pathogenesis of Sjögren's syndrome,” Rheumatic Disease Clinics of North America, vol. 18, no. 3, pp. 517–538, 1992. View at Scopus
  45. N. Haneji, H. Hamano, K. Yanagi, and Y. Hayashi, “A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice,” Journal of Immunology, vol. 153, no. 6, pp. 2769–2777, 1994. View at Scopus
  46. J. Kino-Ohsaki, I. Nishimori, M. Morita, K. Okazaki, Y. Yamamoto, and S. Onishi, “Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome,” Gastroenterology, vol. 110, no. 5, pp. 1579–1586, 1996. View at Publisher · View at Google Scholar · View at Scopus
  47. S. R. Bacman, A. Berra, L. Sterin-Borda, and E. S. Borda, “Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors,” Current Eye Research, vol. 17, no. 12, pp. 1135–1142, 1998. View at Scopus
  48. S. Bacman, L. Sterin-Borda, J. J. Camusso, R. Arana, O. Hubscher, and E. Borda, “Circulating antibodies against rat parotid gland M muscarinic receptors in primary Sjögren's syndrome,” Clinical and Experimental Immunology, vol. 104, no. 3, pp. 454–459, 1996. View at Scopus
  49. M. G. Warnock and J. A. Goodacre, “Cryptic T-cell epitopes and their role in the pathogenesis of autoimmune diseases,” British Journal of Rheumatology, vol. 36, no. 11, pp. 1144–1150, 1997. View at Scopus
  50. Y. Paranyuk, N. Claros, A. Birzgalis, L. C. Moore, P. R. Brink, and B. Walcott, “Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome,” Current Eye Research, vol. 23, no. 3, pp. 199–205, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. M. V. Jonsson, N. Delaleu, K. A. Brokstad, E. Berggreen, and K. Skarstein, “Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland,” Arthritis and Rheumatism, vol. 54, no. 7, pp. 2300–2305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. U. S. Deshmukh, Y. Ohyama, H. Bagavant, X. Guo, F. Gaskin, and S. M. Fu, “Inflammatory stimuli accelerate Sjögren's syndrome-like disease in (NZB x NZW)F1 mice,” Arthritis and Rheumatism, vol. 58, no. 5, pp. 1318–1323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. C. P. Robinson, H. Yamamoto, A. B. Peck, and M. G. Humphreys-Beher, “Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice,” Clinical Immunology and Immunopathology, vol. 79, no. 1, pp. 50–59, 1996. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Rosignoli, V. Roca, R. Meiss, J. Leceta, R. P. Gomariz, and C. P. Leirós, “Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis,” Clinical and Experimental Immunology, vol. 142, no. 3, pp. 411–418, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. M. E. Wildenberg, C. G. van Helden-Meeuwsen, J. P. van de Merwe, H. A. Drexhage, and M. A. Versnel, “Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells,” European Journal of Immunology, vol. 38, no. 7, pp. 2024–2033, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Voulgarelis and A. G. Tzioufas, “Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome,” Nature Reviews Rheumatology, vol. 6, no. 9, pp. 529–537, 2010.
  57. M. G. Humphreys-Beher, S. Yamachika, H. Yamamoto et al., “Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?” European Journal of Morphology, vol. 36, no. 2, pp. 247–251, 1998. View at Scopus
  58. L. Kong, C. P. Robinson, A. B. Peck et al., “Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice,” Clinical and Experimental Rheumatology, vol. 16, no. 6, pp. 675–681, 1998. View at Scopus
  59. GE. Qi, H. Hua, Y. Gao, Q. Lin, and G. Y. Yu, “Sialoadenitis progression in nonobese diabetic mice and its correlation with expression of apoptosis-associated proteins in salivary glands and serum IgG levels,” Chinese Medical Journal, vol. 120, no. 16, pp. 1426–1431, 2007. View at Scopus
  60. M. Ohlsson, K. Skarstein, A. I. Bolstad, A. C. Johannessen, and R. Jonsson, “Fas-induced apoptosis is a rare event in Sjögren's syndrome,” Laboratory Investigation, vol. 81, no. 1, pp. 95–105, 2001. View at Scopus
  61. R. I. Fox and T. Maruyama, “Pathogenesis and treatment of Sjögren's syndrome,” Current Opinion in Rheumatology, vol. 9, no. 5, pp. 393–399, 1997. View at Publisher · View at Google Scholar · View at Scopus
  62. L. J. Dawson, E. A. Field, A. R. Harmer, and P. M. Smith, “Acetylcholine-evoked calcium mobilization and ion channel activation in human labial gland acinar cells from patients with primary Sjögren's syndrome,” Clinical and Experimental Immunology, vol. 124, no. 3, pp. 480–485, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. A. M. Pedersen, S. Dissing, J. Fahrenkrug, J. Hannibal, J. Reibel, and B. Nauntofte, “Innervation pattern and Ca2+ signalling in labial salivary glands of healthy individuals and patients with primary Sjogren's syndrome (pSS),” Journal of Oral Pathology and Medicine, vol. 29, no. 3, pp. 97–109, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. S. C. Van Blokland, C. G. Van Helden-Meeuwsen, A. F. Wierenga-Wolf, et al., “Apoptosis and apoptosis-related molecules in the submandibular gland of the nonobese diabetic mouse model for Sjögren's syndrome: limited role for apoptosis in the development of sialoadenitis,” Lavoratory Investigation, vol. 80, no. 4, pp. 575–585, 2000.
  65. P. Manganelli and P. Fietta, “Apoptosis and Sjögren syndrome,” Seminars in Arthritis and Rheumatism, vol. 33, no. 1, pp. 49–65, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. L. J. Dawson, P. C. Fox, and P. M. Smith, “Sjögrens syndrome—the non-apoptotic model of glandular hypofunction,” Rheumatology, vol. 45, no. 7, pp. 792–798, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. L. S. King, M. Yasui, and P. Agre, “Aquaporins in health and disease,” Molecular Medicine, vol. 6, no. 2, pp. 60–65, 2000. View at Scopus
  68. C. Delporte and S. Steinfeld, “Distribution and roles of aquaporins in salivary glands,” Biochimica et Biophysica Acta, vol. 1758, no. 8, pp. 1061–1070, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. L. Xiao, T. B. Ng, Y. B. Feng, et al., “Dendrobium candidum extract increases the expression of aquaporin-5 in labial glands from patients with Sjögren's syndrome,” Phytomedicine, vol. 18, no. 2-3, pp. 194–198, 2011.
  70. S. Steinfeld, E. Cogan, L. S. King, P. Agre, R. Kiss, and C. Delporte, “Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients,” Laboratory Investigation, vol. 81, no. 2, pp. 143–148, 2001. View at Scopus
  71. D. Beroukas, J. Hiscock, B. J. Gannon, R. Jonsson, T. P. Gordon, and S. A. Waterman, “Selective down-regulation of aquaporin-1 in salivary glands in primary Sjögren's syndrome,” Laboratory Investigation, vol. 82, no. 11, pp. 1547–1552, 2002. View at Scopus
  72. K. Tsubota, S. Hirai, L. S. King, P. Agre, and N. Ishida, “Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjögren's syndrome,” Lancet, vol. 357, no. 9257, pp. 688–689, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. D. Beroukas, J. Hiscock, R. Jonsson, S. A. Waterman, and T. P. Gordon, “Subcellular distribution of aquaporin 5 in salivary glands in primary Sjögren's syndrome,” Lancet, vol. 358, no. 9296, pp. 1875–1876, 2001. View at Publisher · View at Google Scholar · View at Scopus
  74. D. A. Groneberg, C. Peiser, and A. Fischer, “Distribution of salivary aquaporin-5 in Sjögren's syndrome,” Lancet, vol. 359, no. 9319, pp. 1778–1779, 2002. View at Scopus
  75. Y. Sasaki, K. Tsubota, J. D. Kawedia, A. G. Menon, and M. Yasui, “The difference of aquaporin 5 distribution in acinar and ductal cells in lacrimal and parotid glands,” Current Eye Research, vol. 32, no. 11, pp. 923–929, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. C. M. Krane, J. E. Melvin, HA. V. Nguyen et al., “Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation,” Journal of Biological Chemistry, vol. 276, no. 26, pp. 23413–23420, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Moore, T. Ma, B. Yang, and A. S. Verkman, “Tear secretion by lacrimal glands in transgenic mice lacking water channels AQP1, AQP3, AQP4 and AQP5,” Experimental Eye Research, vol. 70, no. 5, pp. 557–562, 2000. View at Publisher · View at Google Scholar · View at Scopus
  78. M. S. Soyfoo, C. De Vriese, H. Debaix et al., “Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy,” Arthritis and Rheumatism, vol. 56, no. 8, pp. 2566–2574, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. H. Nishimura, A. Yakeishi, T. Saga, and K. Yamaki, “Effects of cevimeline on the immunolocalization of aquaporin-5 and the ultrastructure of salivary glands in Sjögren's syndrome model mice,” Kurume Medical Journal, vol. 56, no. 3-4, pp. 39–47, 2009.
  80. Y. T. Konttinen, E. K. Tensing, M. Laine, P. Porola, J. Törnwall, and M. Hukkanen, “Abnormal distribution of aquaporin-5 in salivary glands in the NOD mouse model for Sjögren's syndrome,” Journal of Rheumatology, vol. 32, no. 6, pp. 1071–1075, 2005. View at Scopus
  81. T. Taniguchi and A. Takaoka, “A weak signal for strong responses: interferon-α/β revisited,” Nature Reviews Molecular Cell Biology, vol. 2, no. 5, pp. 378–386, 2001. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Rönnblom and G. V. Alm, “An etiopathogenic role for the type I IFN system in SLE,” Trends in Immunology, vol. 22, no. 8, pp. 427–431, 2001. View at Publisher · View at Google Scholar · View at Scopus
  83. J. M. Anaya, R. D. Mantilla, and P. A. Correa, “Immunogenetics of primary Sjögren's syndrome in Colombians,” Seminars in Arthritis and Rheumatism, vol. 34, no. 5, pp. 735–743, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. U. Båve, G. Nordmark, T. Lövgren et al., “Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism,” Arthritis and Rheumatism, vol. 52, no. 4, pp. 1185–1195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. P. Oxholm, T. E. Daniels, and K. Bendtzen, “Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome,” Autoimmunity, vol. 12, no. 3, pp. 185–191, 1992. View at Scopus
  86. M. Ittah, C. Miceli-Richard, J. E. Gottenberg et al., “Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways,” European Journal of Immunology, vol. 38, no. 4, pp. 1058–1064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. D. A. Horwitz, S. G. Zheng, J. Wang, and J. D. Gray, “Critical role of IL-2 and TGF-β in generation, function and stabilization of Foxp3+ CD4+ Treg,” European Journal of Immunology, vol. 38, no. 4, pp. 912–915, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Banchereau and V. Pascual, “Type I interferon in systemic lupus erythematosus and other autoimmune diseases,” Immunity, vol. 25, no. 3, pp. 383–392, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. U. S. Deshmukh, S. R. Nandula, P. R. Thimmalapura, Y. M. Scindia, and H. Bagavant, “Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function,” Journal of Oral Pathology and Medicine, vol. 38, no. 1, pp. 42–47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. J. E. Gottenberg, N. Cagnard, C. Lucchesi et al., “Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2770–2775, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. N. M. Moutsopoulos, G. E. Katsifis, N. Angelov et al., “Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor α and systemic immune activation,” Annals of the Rheumatic Diseases, vol. 67, no. 10, pp. 1437–1443, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Shiozawa, K. Shiozawa, S. Shimizu et al., “Immunoreactive circulating alpha-interferon is low in Sjögren's syndrome,” British Journal of Rheumatology, vol. 29, no. 1, pp. 50–52, 1990. View at Scopus
  93. T. B. Niewold, T. L. Rivera, J. P. Buyon, and M. K. Crow, “Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus,” Arthritis and Rheumatism, vol. 58, no. 2, pp. 541–546, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. X. Mariette and J. E. Gottenberg, “Pathogenesis of Sjögren's syndrome and therapeutic consequences,” Current Opinion of Rheumatology, vol. 22, no. 5, pp. 471–477, 2010.
  95. M. Voulgarelis and A. G. Tzioufas, “Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome,” Nature Reviews Rheumatology, vol. 6, no. 9, pp. 529–537, 2010.
  96. T. Hayashi, H. Hayashi, T. Fujii, C. Adachi, and K. Hasegawa, “Ultrastructure of myoepithelial cells as a target cell in sialoadenitis of submandibular glands of lupus-prone female NZBxNZWF1 mice,” Virchows Archiv, vol. 453, no. 2, pp. 177–188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. C. Q. Nguyen, H. Kim, J. G. Cornelius, and A. B. Peck, “Development of Sjögren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3,” Journal of Immunology, vol. 179, no. 4, pp. 2318–2329, 2007. View at Scopus
  98. P. Szodoray, P. Alex, J. G. Brun, M. Centola, and R. Jonsson, “Circulating cytokines in primary Sjögren's syndrome determined by a multiplex cytokine array system,” Scandinavian Journal of Immunology, vol. 59, no. 6, pp. 592–599, 2004. View at Publisher · View at Google Scholar · View at Scopus
  99. N. Roescher, P. P. Tak, and G. G. Illei, “Cytokines in Sjögren's syndrome,” Oral Diseases, vol. 15, no. 8, pp. 519–526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. R. Baturone, M. J. Soto, M. Márquez et al., “Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines,” Scandinavian Journal of Rheumatology, vol. 38, no. 5, pp. 386–389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. P. Willeke, H. Schotte, B. Schlüter, et al., “IL-1beta and TNF alpha secreting cells are increased in the peripheral blood of patients with primary Sjögren's syndrome,” Annals of Rheumatic Diseases, vol. 62, no. 4, pp. 359–362, 2003.
  102. A. Solomon, D. Dursun, Z. Liu, Y. Xie, A. Macri, and S. C. Pflugfelder, “Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease,” Investigative Ophthalmology and Visual Science, vol. 42, no. 10, pp. 2283–2292, 2001. View at Scopus
  103. D. A. Jabs, H. C. Gérard, Y. Wei et al., “Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice,” Investigative Ophthalmology and Visual Science, vol. 45, no. 7, pp. 2293–2298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  104. X. Li, K. Wu, M. Edman, et al., “Increased expression of cathepsins and obesity-induced pro-inflammatory cytokines in lacrimal glands of male NOD mouse,” Investigative Ophthalmology & Visual Science, vol. 51, no. 10, pp. 5019–5029, 2010.
  105. H. Hamano, N. Haneji, K. Yanagi, N. Ishimaru, and Y. Hayashi, “Expression of HLA-DR and cytokine genes on interferon-γ-stimulated human salivary gland cell line,” Pathobiology, vol. 64, no. 5, pp. 255–261, 1996. View at Scopus
  106. M. N. Manoussakis, I. D. Dimitriou, E. K. Kapsogeorgou et al., “Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome,” Arthritis and Rheumatism, vol. 42, no. 2, pp. 229–239, 1999. View at Publisher · View at Google Scholar · View at Scopus
  107. T. Hayashi, K. Hasegawa, and C. Adachi, “Elimination of CD4+CD25+ T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZBxNZWF1 mice,” Intenational Journal of Experimental Pathology, vol. 86, no. 5, pp. 289–296, 2005.
  108. T. Hayashi, C. Adachi, and K. Hasegawa, “Systemic treatment of anti-CD4+CD25+ T cell monoclonal antibody exacerbates sialoadenitis in submandibular glands during the early life in lupus-prone female NZB × NZWF1 mice,” Journal of Oral Pathology and Medicine, vol. 38, no. 2, pp. 234–240, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. T. Hayashi, K. Hasegawa, and N. Ichinohe, “ICAM-1 expression on endothelium and systemic cytokine production in cutaneous neutrophilic leucocytoclastic vasculitis in NZBxNZWF1 mice,” Histology and Histopathology, vol. 20, no. 1, pp. 45–52, 2005.
  110. K. Hasegawa and T. Hayashi, “Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB × NZWF1 mice,” Lupus, vol. 12, no. 11, pp. 838–845, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. M. Yamakawa, R. Weinstein, T. Tsuji, J. McBride, D. T. W. Wong, and G. R. Login, “Age-related alterations in IL-1β, TNF-α, and IL-6 concentrations in parotid acinar cells from BALB/c and non-obese diabetic mice,” Journal of Histochemistry and Cytochemistry, vol. 48, no. 8, pp. 1033–1041, 2000. View at Scopus
  112. C. Yao, X. Li, K. Murdiastuti et al., “Lipopolysaccharide-induced elevation and secretion of interleukin-1β in the submandibular gland of male mice,” Immunology, vol. 116, no. 2, pp. 213–222, 2005. View at Publisher · View at Google Scholar · View at Scopus
  113. D. Zoukhri, R. R. Hodges, D. Byon, and C. L. Kublin, “Role, of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia,” Investigative Ophthalmology and Visual Science, vol. 43, no. 5, pp. 1429–1436, 2002. View at Scopus
  114. A. P. Andonopoulos, J. Christodoulou, C. Ballas, A. Bounas, and D. Alexopoulos, “Autonomic cardiovascular neuropathy in Sjögren's syndrome. A controlled study,” Journal of Rheumatology, vol. 25, no. 12, pp. 2385–2388, 1998. View at Scopus
  115. F. Z. J. Cai, S. Lester, T. Lu et al., “Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study,” Arthritis Research and Therapy, vol. 10, no. 2, article R31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. L. Kovacs, M. Papos, R. Takacs, et al., “Autonomic nervous system dysfunction involving the gastrointestinal and the urinary tracts in primary Sjögren's syndrome,” Clinicla Experimental Rheumatology, vol. 21, pp. 697–703, 2003.
  117. T. Mandl, V. Granberg, J. Apelqvist, P. Wollmer, R. Manthorpe, and L. T. H. Jacobsson, “Autonomic nervous symptoms in primary Sjögren's syndrome,” Rheumatology, vol. 47, no. 6, pp. 914–919, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. P. J. Barendregt, M. R. M. Visser, E. M. A. Smets et al., “Fatigue in primary Sjögren's syndrome,” Annals of the Rheumatic Diseases, vol. 57, no. 5, pp. 291–295, 1998. View at Scopus
  119. D. Zoukhri and C. L. Kublin, “Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome,” Investigative Ophthalmology and Visual Science, vol. 42, no. 5, pp. 925–932, 2001. View at Scopus
  120. T. P. Gordon, A. I. Bolstad, M. Rischmueller, R. Jonsson, and S. A. Waterman, “Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis,” Autoimmunity, vol. 34, no. 2, pp. 123–132, 2001. View at Scopus
  121. E. Berggreen, K. Nyløkken, N. Delaleu, H. Hajdaragic-Ibricevic, and M. V. Jonsson, “Impaired vascular responses to parasympathetic nerve stimulation and muscarinic receptor activation in the submandibular gland in nonobese diabetic mice,” Arthritis Research and Therapy, vol. 11, no. 1, article R18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. A. M. Pedersen, S. Dissing, J. Fahrenkrug, J. Hannibal, J. Reibel, and B. Nauntofte, “Innervation pattern and Ca2+ signalling in labial salivary glands of healthy individuals and patients with primary Sjögren's syndrome (pSS),” Journal of Oral Pathology and Medicine, vol. 29, no. 3, pp. 97–109, 2000. View at Publisher · View at Google Scholar · View at Scopus
  123. D. Zoukhri and C. L. Kublin, “Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome,” Investigative Ophthalmolology Visual Science, vol. 42, no. 5, pp. 925–932, 2001.
  124. N. Santavirta, Y. T. Konttinen, J. Törnwall et al., “Neuropeptides of the autonomic nervous system in Sjögren's syndrome,” Annals of the Rheumatic Diseases, vol. 56, no. 12, pp. 737–740, 1997. View at Scopus
  125. M. G. Humphreys-Beher, J. Brayer, S. Yamachika, A. B. Peck, and R. Jonsson, “An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression,” Scandinavian Journal of Immunology, vol. 49, no. 1, pp. 7–10, 1999. View at Scopus
  126. S. I. Mellgren, L. G. Göransson, and R. Omdal, “Primary Sjögren's syndrome associated neuropathy,” Canadian Journal of Neurological Sciences, vol. 34, no. 3, pp. 280–287, 2007. View at Scopus
  127. P. Ewert, S. Aguilera, C. Alliende et al., “Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposure,” Arthritis and Rheumatism, vol. 62, no. 5, pp. 1280–1289, 2010. View at Publisher · View at Google Scholar · View at Scopus
  128. O. J. Baker, J. M. Camden, R. S. Redman et al., “Proinflammatory cytokines tumor necrosis factor-α and interferon-γ alter tight junction structure and function in the rat parotid gland Par-C10 cell line,” American Journal of Physiology, vol. 295, no. 5, pp. C1191–C1201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. C. Molina, C. Alliende, S. Aguilera, et al., “Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjögren's syndrome: association with mononuclear cell infiltration,” Annals of Rhematic Diseases, vol. 65, no. 2, pp. 178–183, 2006.
  130. C. P. McArthur, N. W. Fox, and P. Kragel, “Monoclonal antibody detection of laminin in minor salivary glands of patients with Sjögren's Syndrome,” Journal of Autoimmunity, vol. 6, no. 5, pp. 649–661, 1993. View at Publisher · View at Google Scholar · View at Scopus
  131. T. Hayashi, T. Shirachi, and K. Hasegawa, “Relationship between sialoadenitis and periductal laminin expression in the submandibular salivary gland of NZBxNZWF1 mice,” Journal of Comparative Pathology, vol. 125, no. 2-3, pp. 110–116, 2001.
  132. P. Defilippi, L. Silengo, and G. Tarone, “Alpha 6.beta 1 integrin (laminin receptor) is down-regulated by tumor necrosis factor alpha and interleukin-1 beta in human endothelial cells,” Journal of Biological Chemistry, vol. 267, no. 26, pp. 18303–18307, 1992.
  133. P. Porola, M. Laine, I. Virtanen, R. Pöllänen, B. D. Przybyla, and Y. T. Konttinen, “Androgens and integrins in salivary glands in Sjögren's syndrome,” Journal of Rheumatology, vol. 37, no. 6, pp. 1181–1187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. D. A. Sullivan, B. D. Sullivan, J. E. Evans et al., “Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye,” Annals of the New York Academy of Sciences, vol. 966, pp. 211–222, 2002. View at Scopus
  135. L. Kovács, T. Török, F. Bari et al., “Impaired microvascular response to cholinergic stimuli in primary Sjögren's syndrome,” Annals of the Rheumatic Diseases, vol. 59, no. 1, pp. 48–53, 2000. View at Publisher · View at Google Scholar · View at Scopus
  136. T. Hayashi, “Environmental factors and concepts in the induction of type 1 diabetes,” in Hand book of Type 1 Diabetes Mellitus, T. Hayashi, Ed., pp. 1–54, Nova Science, 2010.